30-Oct-2026 14:21:24

SUN PHARMA Q2 FY27 : ACTUAL VS ESTIMATES

• NET PROFIT AT ₹2,501 CR VS EST ₹3,085 CR — MISS BY 18.93% 🔴 • REVENUE AT ₹16,198.7 CR VS EST ₹15,766.1 CR — BEAT BY 2.74% 🟢 • EBITDA AT ₹4,743.5 CR VS EST ₹4,403 CR — BEAT BY 7.73% 🟢 • EBITDA MARGINS AT 29.3% VS EST 27.9% — BEAT BY 140 BPS 🟢

SUN PHARMACEUTICAL IND L

← Back to feed